SPECIES DIFFERENCES IN THE KINETICS AND METABOLISM OF FENFLURAMINE ISOMERSCACCIA S; BALLABIO M; GUISO G et al.1982; ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE; ISSN 0003-9780; BEL; DA. 1982; VOL. 258; NO 1; PP. 15-28; BIBL. 22 REF.Article

TRAITEMENT DE L'OBESITE AVEC LA FENFLURAMINE. EXPERIENCES CLINIQUES ET RAPPORTS BIOCHIMIQUESGUEMES DIAZ JF.1973; VIE MED. CANADA FR.; CANADA; DA. 1973; VOL. 2; NO 3; PP. 232-245Serial Issue

ETUDE EN DOUBLE INSU AVEC PERMUTATION CROISEE D'UNE SUBSTANCE ANOREXIGENE: LE CLOBENZOREXMIROUZE J; MARY P; LAPINSKI H et al.1973; J. MED. MONTPELLIER; FR.; DA. 1973; VOL. 8; NO 2; PP. 115-123 (5P.)Serial Issue

UN REEDUCATEUR DU COMPORTEMENT ALIMENTAIRE: LE CLOBENZOREX1972; REV. MED. TOULOUSE, ENSEIGN. DOCUM. INFORM.; FR.; DA. 1972; VOL. 8; NO 7; PP. 1253-1260 (5P.); BIBL. 5REF.Serial Issue

DIBOTIN (PHENFORMINE) DANS LE TRAITEMENT DE L'OBESITEMISKIEWICZ H.1972; WIADOM. LEK.; POLSKA; DA. 1972; VOL. 25; NO 21; PP. 1931-1934; ABS. RUSSE ANGL.; BIBL. 21REF.Serial Issue

FACTORS INFLUENCING TOLERANCE TO D-AMPHETAMINE-INDUCED ANOREXIA IN RATSMILLOY S; GLICK SD.1976; ARCH. INTERNATION. PHARMACODYN. THERAP.; BELG.; DA. 1976; VOL. 221; NO 1; PP. 87-95; BIBL. 10 REF.Article

FENFLURAMINE AND 5-HYDROXYTRYPTAMINE. II. INVOLVEMENT OF BRAIN 5-HYDROXYTRYPTAMINE IN THE ANORECTIC ACTIVITY OF FENFLURAMINE. = FENFLURAMINE ET 5-HYDROXYTRYPTAMINE. II. ROLE DE LA 5-HYDROXYTRYPTAMINE CEREBRALE DANS L'ACTIVITE ANOREXIGENE DE LA FENFLURAMINEDUHAULT J; BOULANGER M; VOISIN C et al.1975; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1975; VOL. 25; NO 11; PP. 1758-1762; ABS. ALLEM.; BIBL. 22 REF.Article

FENFLURAMINE IN THE TREATMENT OF OBESITYSTUNKARD A; RICKELS K; HESBACHER P et al.1973; LANCET; G.B.; DA. 1973; NO 7802; PP. 503-505; BIBL. 26REF.Serial Issue

ASPECTS EPIDEMIOLOGIQUES DE LA TOXICOMANIE AUX ANOREXIGENESVAILLE C.1979; THERAPIE; FRA; DA. 1979; VOL. 34; NO 2; PP. 221-247; ABS. ENG; BIBL. 85 REF.Article

DETERMINAZIONE DELLA CONFIGURAZIONE ASSOLUTA DI COMPOSTI AMMINICI AVENTI INTERESSE FARMACEUTICO ATTRAVERSO MISURE DI DICROISMO CIRCOLARE = DETERMINATION DE LA CONFIGURATION ABSOLUE DE DERIVES AMINES, AYANT UN INTERET PHARMACEUTIQUE, AU MOYEN DU DICHROISME CIRCULAIREBETTONI G; FRANCHINI C.1976; FARMACO, ED. SCI.; ITAL.; DA. 1976; VOL. 31; NO 2; PP. 105-111; ABS. ANGL.; BIBL. 5 REF.Article

CHLORPHENTERMINE INDUCED ULTRASTRUCTURAL ALTERATIONS IN FOETAL TISSUE = ALTERATIONS ULTRASTRUCTURALES DU TISSU FOETAL INDUITES PAR LA CHLORPHENTERMINELULLMAN RAUCH R.1973; VIRCHOWS ARCH., B; DTSCH.; DA. 1973; VOL. 12; NO 4; PP. 295-302; BIBL. 8 REF.Serial Issue

SPECIFICALLY DEUTERATED 1-PHENYLISOPROPYLAMINES. II. SYNTHESIS OF DEUTERIUM LABELLED PHENTERMINELINDEKE B; CHO AK; FEDORCHUK M et al.1972; ACTA PHARM. SUECICA; SUEDE; DA. 1972; VOL. 9; NO 6; PP. 605-608; BIBL. 6REF.Serial Issue

EFFICACITE DE LA FENFLURAMINE EN TANT QU'AUXILLIAIRE DU TRAITEMENT DIETETIQUE DE L'OBESITEBLONDHEIM SH; ROZEN P; SUPERSTINE E et al.1972; HAREFUAH; ISRAEL; DA. 1972; VOL. 83; NO 9; PP. 365-367; ABS. ANGL.; BIBL. 8REF.Serial Issue

FENFLURAMINE AND DERIVATIVES. PROCEEDINGS OF A SYMPOSIUM; MARBELLA, SPAIN; 19741975; POSTGRAD. MED. J., SUPPL.; G.B.; DA. 1975; VOL. 51; NO 1; PP. 1-189; BIBL. DISSEM.Conference Paper

TRAITEMENT DES FORTES OBESITES PAR LA FENFLURAMINE A FORTES DOSESSPROULE BC.1973; VIE MED. CANADA FR.; CANADA; DA. 1973; VOL. 2; NO 2; PP. 163-165Serial Issue

LE ROLE DES AGENTS ANOREXIQUES ET DES AUTRES MEDICAMENTS DANS LE TRAITEMENT DE L'OBESITELAURENT LPE.1972; VIE MED. CANADA FR.; CANADA; DA. 1972; VOL. 1; NO 5; PP. 491-493; BIBL. 2REF.Serial Issue

ANOREXIGENIC EFFECTS OF METOCLOPRAMIDE IN RATSALPHIN RS; BUCHHOLZ S; WARD JW et al.1972; EUROP. J. PHARMACOL.; NETHERL.; DA. 1972; VOL. 20; NO 2; PP. 241-242; BIBL. 6REF.Serial Issue

Pharmacological manipulation of sincalide (CCK-8)-induced suppression of feedingWILSON, M. C; DENSON, D; BEDFORD, J. A et al.Peptides (New York, NY. 1980). 1983, Vol 4, Num 3, pp 351-357, issn 0196-9781Article

ETUDE PAR SPECTROSCOPIE RAMAN DE QUELQUES ANOREXIGENES. I: ANOREXIGENES N-SUBSTITUESGAMOT AP; VERGOTEN G; FLEURY G et al.1981; TALANTA (OXF.); ISSN 0039-9140; GBR; DA. 1981; VOL. 28; NO 2; PP. 95-105; ABS. ENG; BIBL. 7 REF.Article

MAZINDOL SELF-ADMINISTRATION IN THE RHESUS MONKEYWILSON MC; SCHUSTER CR.1976; PHARMACOL. BIOCHEM. BEHAV.; U.S.A.; DA. 1976; VOL. 4; NO 2; PP. 207-210; BIBL. 6 REF.Article

SOLVOLYSIS OF A SUBSTITUTED IMIDAZOLINE, MAZINDOL.MAULDING HV; TURI P; GROSSMAN D et al.1975; J. PHARM. SCI.; U.S.A.; DA. 1975; VOL. 64; NO 11; PP. 1833-1838; BIBL. 8 REF.Article

A NON-AMPHETAMINE ANORECTIC AGENT: PRECLINICAL BACKGROUND AND A DOUBLE-BLIND CLINICAL TRIAL. = UN AGENT ANOREXIGENE NON AMPHETAMINIQUE: DONNEES DE BASE PRECLINIQUES ET ESSAI CLINIQUE EN DOUBLE AVEUGLESCHWARTZ LN.1975; J. INTERNATION. MED. RES.; G.B.; DA. 1975; VOL. 3; NO 5; PP. 328-332; BIBL. 12 REF.Article

COMPARISON OF A NEW ANORECTIC AGENT AN448 WITH FENFLURAMINE IN THE TREATMENT OF REFRACTORY OBESITY = COMPARAISON ENTRE UN NOUVEL ANOREXIGENE LE AN-448, ET LA FENFLURAMINE DANS LE TRAITEMENT DE L'OBESITE REFRACTAIREGOLDRICK RB; NESTEL PJ; HAVENSTEIN N et al.1974; MED. J. AUSTRAL.; AUSTRAL.; DA. 1974; VOL. 1; NO 22; PP. 882-885; BIBL. 18REF.Article

FENFLURAMINE BLOCKADE OF CNS STIMULANT EFFECTS OF AMPHETAMINES = LE BLOCAGE PAR LA FENFLURAMINE DES EFFETS STIMULANTS DES AMPHETAMINES SUR LE SNCBERGER HJ; BROWN CC; KRANTZ JC JR et al.1973; J. PHARM. SCI.; U.S.A.; DA. 1973; VOL. 62; NO 5; PP. 788-791; BIBL. 14REF.Serial Issue

HYPOTHALAMIC FEEDING MECHANISMS AND AMPHETAMINE ANOREXIA = MECANISMES ALIMENTAIRES AU NIVEAU DE L'HYPOTHALAMUS ET ANOREXIE A L'AMPHETAMINECOLE SO.1973; PSYCHOL. BULL.; U.S.A.; DA. 1973; VOL. 79; NO 1; PP. 13-20; BIBL. 3 P.Serial Issue